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AF was shown in 78% (14/18): APC only Initiated AF, not involved in the maintenance of 
AF. Triggering AF by APC was related to wave break-up at the septopulmonary bundle 
near the RSPV ostium in 55% (lO/ZO), posterior roof of LA in 35% (7120). 2) Focally 
driven AF was shown in 22% (4/18): APCs not only initiated AF but also played a role in 
the maintenance of AF. During AF, these APCs were continuously generated from the 
arrhythmogenic foci and activated the LA. The wave propagation patterns of induced AF 
were different from those of spontaneous AF in 54.5% of patients. APC originated from 
single PV was in 45% (g/20), two PVs 15% (3/20) and more than three PVs 20% (4120). 
Non-PV foci were identified in 37.5% (6116) of the patients and mostly located at the pos- 
terior roof of the LA (12.5%, 2/16). 
Conclusion: A non-contact mapping system may facilitate identification of the mecha- 
nwns and the relationship with the underlying anatomvzzal structures responsible for the 
initiation and maintenance of AF. 
1089-14 C-Reactive Protein in Atrial Fibrillation: Evidence for the 
Presence of Inflammation in the Genesis and 
Perpetuation of the Arrhythmia 
Monica Acevedo, Ramon L. Corbalan. LUIS Perez, Sandra Braun, Jaime Pereira, Teresa 
Lira, Carlos Navarrete, Catholic University Hospital, Santiago, Chile 
Background: Atrial fibrillation (AF) is associated to a number of clinlcal entities with an 
underlying acute or chronic inflammatory process. It is possible that inflammation could 
contribute to the initiation and perpetuation of this arrhythmia. 
Alms: To evaluate the presence of an inflammatory process in patients with newly diag- 
nosed non valvular AF. 
Methods: We studied 109 consecutive patients admitted for newly diagnosed AF. Forty 
patients resulted in chronic AF and 69 had paroxysmal AF. All patients had determina- 
tions of C reactive protein (CRP) at basellne and at 30 days, 68 had CRP at 1 year of fol- 
low-up. In addition the patients were evaluated clinically and with general laboratory 
tests. A transesophageal echocardiogram (TEE) was performed withln the first 24 hours 
of admission to evaluate left atrial and ventricular dimensions, LV funcbon and the pres- 
ence of spontaneous echo contrast or intracavitary thrombus. 
Results: Mean age was 67 -t 14 years and 50% were z-70 years. Hypertension was found 
I” 57%, diabetes I” 17% and cardiomyopathy in 36% of cases. A history of previous sys- 
temlc embolism was present in 6 patients. Relevant TEE findings were left atrial diameter 
>45 mm in 52%, left ventricular dysfunction in 15% and the presence of spontaneous 
echo contrast and or LA thrombus I” 53% of cases. CRP levels in the whole group were 
l.O*l.E mg/dl, 0.9k1.4 mg/dl I” patients with paroxysmal AF and I.12 2.4 mgidl in 
patients with chronic AF (p=O.OOl AF group, p=O.Ol paroxysmal AF group and p=O.Ol 
chronic AF group vs 20 normal sublects in sinus rhythm). CRP levels correlated with 
other laboratory markers of inflammation (VHS, p=O.O03 and WBC, p= 0.004) and with 
the presence of LV dysfunction in TEE (p = 0.02) in multivariate analysis. At 30 days 
there was a significant decrease in CRP both I” chronic and paroxysmal AF ( p= 0.048 
and 0.03 respectwely). At 1 year of follow up mean CRP levels in patients that were still 
in AF were 1 .&I .8 mg/dL, whereas in those with sinus rhythm were 0.5iO.5 mg/dL, p = 
0.048) 
Conclusion: This study prowdes evidence for the presence of an inflammatory process in 
patlents with newly diagnosed non valvular AF. The perslstence of inflammation is asso- 
ciated with chronic AF at 1 year of follow up. 
1089-15 Plasma Amino-Terminal Pro-B-Type Natriuretic Peptide 
Predicts Postcardioversion Reversion to Atrial 
Fibrillation 
A. Mark Richards, John G. Lainchbury, Richard W. Troughton. Gary Nicholls, Chris M 
Frampton. Timothv G. Yandle. Christchurch Cardloendocrw Research Group. 
Christchurch, New Zealand 
Background: With mounting evidence that rate control plus anticoagulation IS the treat- 
ment of choice for chronic atrial fibrillation (AF), there is a need to improve patient selec- 
tion for electrical cardioversion (CV) from AF by more accurate predlctlon of those likely 
to exhibit sustained return to sinus rhythm. 
Methods: Plasma cardiac natriuretic peptides (NPs, including ANP. BNP and pro-amino- 
terminal BNP [N-BNP]) and adrenomedullin (ADM) were assayed before, immediately 
after and six weeks aftdrcardioversion in 151 patients with chronic AF. 
Results: Plasma NPs (but not ADM) fell significantly immediately postsuccessful CV (all 
pcO.0001) but not in 15 patients in which CV failed. At SIX months postCV, 65 patients 
remained in sinus rhythm whilst 86 were in AF. Plasma NPs (but not ADM) were signifi- 
cantly higher at all three sampling times in those destined to be in AF at six months. 
Kaplan-Meier analysis indicated significant separation of AF-free suwival curves by 
median preCV and immediate postCV levels of BNP (p=O.O39 and 0.0024 respectively) 
and N-BNP (p=O.O22 and 0.010) but not ANP (p=O.O75 and 0.063) or ADM (p=O.425 and 
0.253). Tertiles of precardioversion N-BNP differed slgmficantly for risk of AF at SIX 
months (39, 60 and 70% risk in frst, second and third tertiles respectively; p=O.O06). Mul- 
tiple regression analysis indicated both pre and immediate postcardioversion levels of 
BNP (p=O.Ol and 0.009) and N-BNP (p=O.O06 and 0.011) were predictive of reversion to 
AF independent of age, left ventricular function or the prophylactic prescription of beta 
blocketslamiodarone. 
Conclusions: In patients with chronic AF, those with plasma N-BNP concentrations ele- 
vated above the lowest tertile may be more rationally treated with rate control and antico- 
agulation rather than undergoing single or serial electrlcal cardwersion. 
1089-18 C-Reactive Protein and Microalbuminuria Are 
Associated With Atrial Fibrillation 
Folkert W. Asselberqs Gilles F. Diercks. Maarten P. van den Berg, Ad J. van Boven, 
lsabelle C. van Gelder, Dirk J. van Veldhuisen. Wiek H. van Gilst, University of 
Groningen, Groningen. The Netherlands, University Hospital Groningen, Groningen, The 
Netherlands 
Background: Atrial flbrlllation (AF) is a major risk factor for stroke and cardiac events. 
Early identification of subjects at risk for AF might help to prevent the onset of AF. The 
inflammatory marker C-reactive protein (CRP) and mwoalbuminuria are easy to obtain 
risk indicators for ischemic heart disease. lschemlc heart disease is one of the most 
important predisposing factor for AF. In this study, we hypothesized that CRP and 
microalbuminuria are associated with AF. 
Methods: In a large population based survey (8501 subjects), atrial fibrillation was mea- 
sured by one 12 lead electrocardiogram and defined according to Minnesota codes 8.3.1 
and 8.3.3. Mean age was 49 + 12.7 years and 49.8% male. Microalbuminuria was 
defined as 30-300 mgi24h. High sensitive CRP was dichotomized (three lowest quartile, 
CRP< 2.97 mg/l versus the highest quartile, CRP, 2.97 mg/l). The following cardiovascu- 
lar risk factors were assessed and used in the analysis: age, sex, hypertension, hyperc- 
holesterolemia, obesity, diabetes mellitus, smoking, ischemic heart disease, and left 
ventricular hypertrophy. 
Results: Atrial fibrillation was present in 75 (0.9 %) subjects. AF was significantly associ- 
ated with the highest quartile of CRP (2.63 [1.71-4.051, p-zO.001) and microalbuminuria 
(3.46 [2.18-5.491, pcO.001). When all cardiovascular risk factors were entered simulta- 
neously, CRP (2.09 [1.29-3.401. p=O.O03) and microalbuminurla (2.08 [I .21-3.501, 
p=O.OOE) remained significantly associated with AF. The combination of the highest quar- 
tile of CRP and the presence of microalbuminuria showed a higher association with AF 
(7.36 [4.16-13.01], pcO.OOl), even after adjusting for all cardiovascular risk factors (4.07 
[2.08-7.951, p<O.OOl). 
Conclusion: In this study, we demonstrated that C-reactwe protein, microalbuminuria, 
and the combination of both are associated with atrium ffbrillation independent of cardio- 
vascular risk factors. 
1089-17 Is Atrial Fibrillation an Inflammatory Disease Reflected 
by Elevated C-Reactive Protein? 
Chloe A. Allen Mavccxk Donald L. LappB, Brian G. Crandall, Joseph 8. Muhlestein, 
Benjamin D. Home, Tami L. Bair, Qunyu Li, Sandra P. Reyna, Dale G. Renlund, Jeffrey 
L. Anderson, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Background Inflammation is implicated in the pathogenesis of cardiovascular diseases. 
C-reactive protein (CRP), a marker of systemic inflammation, predicts increased risk of 
coronary events and stroke. Atrial fibrillation (AF) is associated with cardiac structural 
changes, including atrial fibrosis, which may have an inflammatory basis. In a recent 
small retrospective study, patients (pts) with AF had higher CRP levels than controls. We 
prospectively tested the hypothesis that CRP is a risk factor for AF in a large cohort. 
Methods Consecutive pts (Nc3.357) free from myocardial infarction had a CRP level 
drawn at the time of angiography. These pts were enrolled in the Registry of the Inter- 
mountain Heart Collaborative Study between 1994-2001. Those with 21 ECG showing 
AF during the study period formed the disease group (1x347). Those with neither ECG 
nor clinical (ICD-9) evidence for AF comprised the control (C) group (n=2449). The other 
561 were excluded. CRP was measured by fluorescence polarization immunoassay 
(Abbott). Logistic regression assessed quartile (Q) of CRP and 13 other clinical and 
angiographic variables as predictors of AF. 
Results Average age was 63+12 years; 33% were women; 61% had significant core- 
nary artery disease (CAD), and 26%. no CAD; median CRP was 1.21 mg/dL. AF pts 
were older (by 7 years) and more frequently had a history of heart fatlure (HF) than C pts 
(41% vs. 10%) (both p<O.OOl). CRP was higher in AF than C pts (1.97 vs. 1.51 mg/dL, 
p<O.OOl). Q-CRP was a univariable predictor of AF (odds ratio [OR]=l.39/Q, Cl 1.25. 
1.55, p<O.OOl). After adjustmg for age and HF, the predictive value of Q-CRP was 
reduced but retained significance (OR=l.ZO/Q, Cl 1.07-I .34, p=O.OOZ). Further adjusting 
for 11 other variables had little effect (OR=1 .19/Q. CI=l.O6-1.33, p=O.O03) 
Conclusion: Increasing CRP independently predicted an Increased risk of AF among a 
large, prospectively studied patient cohort assessed anglographically. These results sup- 
port the proposal that AF pathophysiology includes an inflammatory mechanism. that ele- 
vated CRP is a new risk marker for AF propensity, and that AF therapies targeting 
inflammation are worthy of testing. 
1089-18 Altered Collagen Subpopulations and the Matrix 
Metalloproteinase Regulation in the Development of 
Atrial Fibrillation in Atrial Dysfunction 
Jun Guanggen Cui, Fardad Esmailian, Mark Plunkett, Daniel Marelli, Abbas Ardehali, 
Jonah Odim, Hillel Laks, Luyi Sen, UCLA Medical Center/UCLA School of Medicine, Los 
Angeles, CA 
BackgroundMyocardial remodeling has been found not only in ventricle. but also in 
atrium in dilated cardiomyopathy and heart failure. We hypothesize that atrlal extracellu- 
lar matw remodeling may be responsible for the AFib recurrence and maintenance in 
atria1 dysfunction. 
Methods and Results Tissue samples from 55 hearts explanted from patients with 
dilated cardiomyopathy and end-stage heart failure underwent heart transplantation were 
examined. Nineteen patients had permanent AFib (PmAF), 20 had persistent AFlb 
(PsAF) and 16 had no documented AFib (NAF). Sixteen donor leff atrium were used as 
normal control (CN). Fibrillar collagen subtype I and III distributions in the left atrium (LA) 
were exammed by lmmunofluoresent staining. LA metalloproteinase-1 and 2 (MMP-I. 
MMP-P), tissue inhibitor of metalloproteinase-1 and 2 (TIMP-I, TIMP-2) proteins were 
evaluated by western blot. Type I collagen volume fraction (CVF-I) increased significantly 
